C28H31BrN2O2
507.5 g/mol
APIWarning
Darifenacin hydrobromide
CAS133099-07-7
Category
API
Compound Class
Amine
Primary Use
Pharmaceutical Raw Material
Darifenacin hydrobromide is the hydrobromide salt of darifenacin, a selective antagonist for the M3 muscarinic acetylcholine receptor. It is used in the management of urinary incontinence and serves as an active pharmaceutical ingredient in pharmaceutical manufacturing.
active pharmaceutical ingredient for antimuscarinic formulationspharmaceutical raw material for urinary incontinence managementresearch compound for muscarinic receptor studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 133099-07-7
Related Compounds
StrongSame Parent
Darifenacin
CAS133099-04-4
pharmaceutical raw material
ReferenceSame Category
Insulin Lispro
CAS133107-64-9
pharmaceutical raw material
ReferenceSame Category
Flutamide
CAS13311-84-7
pharmaceutical raw material
ReferenceSame Category
Apalutamide metabolite M2
CAS1332391-92-0
pharmaceutical raw material
ReferenceSame Category
O-Acetyl Octreotide
CAS133304-81-1
pharmaceutical raw material
Safety Reference
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name
2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide
InChIKey
UQAVIASOPREUIT-VQIWEWKSSA-N
SMILES
C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br
Synonyms (28)
- Darifenacin hydrobromide (JAN/USAN)
- Darifenacin hydrobromide, United States Pharmacopeia (USP)
- 133099-07-7 (HBr)
- Darifenacin 15 mg
- Darifenacin 7.5 mg
- Darifenacin hydrobromide
- Darilong
- Emselex
- Enablex
- Enablex (TN)
- UK 88525-04 hydrobromide
- Uk-88525-04 (hbr)
- darifenacin HBr